Novavax CEO explains delay in COVID-19 vaccine EUA filing – Yahoo Finance

Novavax (NVAX) announced Thursday it would have to push back its COVID-19 vaccine emergency use authorization (EAU) filing with the FDA by about one month, once again, this time due to manufacturing … [+3837 chars]